$16.81
0.21.20%
At Close: -
$16.79
-0.02-0.12%
After Hours: 4:46 PM EDT
15 minutes delayed
Comments
Loading...
SI-BONE
SIBNNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
SI-BONE (NASDAQ:SIBN) Stock, Analyst Ratings, Price Targets, Forecasts
SI-BONE Inc has a consensus price target of $27 based on the ratings of 12 analysts. The high is $40 issued by Morgan Stanley on August 3, 2021. The low is $20 issued by Jefferies on October 12, 2022. The 3 most-recent analyst ratings were released by Morgan Stanley, JMP Securities, and Needham on July 15, 2024, May 7, 2024, and May 7, 2024, respectively. With an average price target of $26.67 between Morgan Stanley, JMP Securities, and Needham, there's an implied 58.82% upside for SI-BONE Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
JMP Securities
Needham
Piper Sandler
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for SI-BONE
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/15/2024 | Buy Now | 25.07% | Morgan Stanley | Drew Ranieri | $25 → $21 | Maintains | Overweight | Get Alert |
| 05/07/2024 | Buy Now | 90.59% | JMP Securities | David Turkaly | → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/07/2024 | Buy Now | 60.81% | Needham | David Saxon | → $27 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 48.9% | Morgan Stanley | Drew Ranieri | $26 → $25 | Maintains | Overweight | Get Alert |
| 04/03/2024 | Buy Now | 60.81% | Needham | David Saxon | → $27 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 48.9% | Piper Sandler | Matt O'Brien | → $25 | Initiates | → Overweight | Get Alert |
| 02/27/2024 | Buy Now | 54.85% | Morgan Stanley | Drew Ranieri | $25 → $26 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 48.9% | Cantor Fitzgerald | Ross Osborn | $25 → $25 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | 42.94% | Truist Securities | Samuel Brodovsky | $26 → $24 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | Buy Now | 54.85% | Truist Securities | David Rescott | $25 → $26 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | 48.9% | Needham | David Saxon | → $25 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | 48.9% | Cantor Fitzgerald | Ross Osborn | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 48.9% | Morgan Stanley | Drew Ranieri | $30 → $25 | Maintains | Overweight | Get Alert |
| 11/07/2023 | Buy Now | 48.9% | Needham | David Saxon | $32 → $25 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 78.68% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 78.68% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/09/2023 | Buy Now | 78.68% | Cantor Fitzgerald | Ross Osborn | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/08/2023 | Buy Now | 84.63% | Truist Securities | David Rescott | $33 → $31 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | 90.59% | Needham | David Saxon | → $32 | Reiterates | Buy → Buy | Get Alert |
| 07/19/2023 | Buy Now | 96.55% | Truist Securities | David Rescott | $28 → $33 | Maintains | Buy | Get Alert |
| 07/12/2023 | Buy Now | 90.59% | Needham | David Saxon | $27 → $32 | Maintains | Buy | Get Alert |
| 05/31/2023 | Buy Now | 78.68% | Morgan Stanley | Drew Ranieri | $27 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 78.68% | Cantor Fitzgerald | Ross Osborn | $24 → $30 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 60.81% | Morgan Stanley | Drew Ranieri | $22 → $27 | Maintains | Overweight | Get Alert |
| 05/02/2023 | Buy Now | 90.59% | JMP Securities | David Turkaly | → $32 | Reiterates | → Market Outperform | Get Alert |
| 05/02/2023 | Buy Now | 60.81% | Canaccord Genuity | Kyle Rose | $24 → $27 | Maintains | Buy | Get Alert |
| 05/02/2023 | Buy Now | 60.81% | Needham | David Saxon | $24 → $27 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 54.85% | Truist Securities | David Rescott | $21 → $26 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 42.94% | Cantor Fitzgerald | Ross Osborn | $22 → $24 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 42.94% | Canaccord Genuity | Kyle Rose | $21 → $24 | Maintains | Buy | Get Alert |
| 02/28/2023 | Buy Now | 31.03% | Morgan Stanley | Drew Ranieri | $18 → $22 | Maintains | Overweight | Get Alert |
| 02/28/2023 | Buy Now | 42.94% | Needham | David Saxon | $20 → $24 | Maintains | Buy | Get Alert |
| 01/31/2023 | Buy Now | 25.07% | Truist Securities | Richard Newitter | $17 → $21 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 7.21% | Morgan Stanley | Drew Ranieri | $21 → $18 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 1.25% | Truist Securities | David Rescott | $20 → $17 | Maintains | Buy | Get Alert |
| 11/08/2022 | Buy Now | 25.07% | Morgan Stanley | Drew Ranieri | $22 → $21 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 90.59% | JMP Securities | David Turkaly | $36 → $32 | Maintains | Market Outperform | Get Alert |
| 11/08/2022 | Buy Now | 31.03% | Needham | David Saxon | $24 → $22 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | 19.12% | Jefferies | Matthew Taylor | → $20 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 31.03% | Morgan Stanley | Drew Ranieri | $21 → $22 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 25.07% | Morgan Stanley | Drew Ranieri | $18 → $21 | Maintains | Overweight | Get Alert |
| 08/09/2022 | Buy Now | 42.94% | Needham | David Saxon | $28 → $24 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 7.21% | Morgan Stanley | Drew Ranieri | $22 → $18 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 31.03% | Morgan Stanley | Drew Ranieri | $28 → $22 | Maintains | Overweight | Get Alert |
| 05/10/2022 | Buy Now | 66.77% | Needham | David Saxon | $30 → $28 | Maintains | Buy | Get Alert |
| 03/01/2022 | Buy Now | 66.77% | Morgan Stanley | Drew Ranieri | $30 → $28 | Maintains | Overweight | Get Alert |
| 01/18/2022 | Buy Now | 114.41% | B of A Securities | Craig Bijou | $43 → $36 | Maintains | Buy | Get Alert |
| 12/21/2021 | Buy Now | 78.68% | Truist Securities | David Rescott | $35 → $30 | Maintains | Buy | Get Alert |
| 11/09/2021 | Buy Now | 114.41% | JMP Securities | David Turkaly | — | Maintains | Market Outperform | Get Alert |
| 08/03/2021 | Buy Now | 138.24% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 08/03/2021 | Buy Now | 120.37% | Needham | David Saxon | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for SI-BONE (SIBN) stock?
The latest price target for SI-BONE (NASDAQ:SIBN) was reported by Morgan Stanley on July 15, 2024. The analyst firm set a price target for $21.00 expecting SIBN to rise to within 12 months (a possible 25.07% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for SI-BONE (SIBN)?
The latest analyst rating for SI-BONE (NASDAQ:SIBN) was provided by Morgan Stanley, and SI-BONE maintained their overweight rating.
When was the last upgrade for SI-BONE (SIBN)?
There is no last upgrade for SI-BONE
When was the last downgrade for SI-BONE (SIBN)?
There is no last downgrade for SI-BONE.
When is the next analyst rating going to be posted or updated for SI-BONE (SIBN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
Is the Analyst Rating SI-BONE (SIBN) correct?
While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a maintained with a price target of $25.00 to $21.00. The current price SI-BONE (SIBN) is trading at is $16.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.